Cite
APA Citation
Alten, R., Lorenz, H., Mariette, X., Nüßlein, H., Galeazzi, M., Navarro, F., Chartier, M., Heitzmann, J., Rauch, C., & Bars, M. L. (n.d.). aB0412 Less than 5% of real-life patients who switch from iv to sc abatacept in real-world clinical practice subsequently switch back to the iv formulation. Annals of the rheumatic diseases, 76, 1193–1194. http://access.bl.uk/ark:/81055/vdc_100135161961.0x000062